
zzso remains the zzso for men diagnosed with zzso zzso prostate cancer zzso However, only approximately 50% of patients benefit from treatment and all develop zzso zzso Here, we characterize global zzso in zzso zzso signaling associated with zzso resistance and thereby develop a potential therapeutic strategy to reverse this zzso Using quantitative mass zzso zzso we identified that zzso zzso prostate cancer cell lines zzso and zzso exhibit increased zzso of focal zzso zzso zzso on zzso and zzso in comparison with parental controls zzso and zzso zzso zzso analyses identified zzso in pathways regulating focal zzso and the zzso zzso and in zzso interaction networks related to these pathways in zzso zzso Treatment with the zzso zzso zzso inhibitor zzso zzso reduced zzso zzso in the resistant cells, but did not affect cell viability or zzso zzso zzso administration reduced zzso and zzso zzso whereas zzso with zzso and zzso resulted in an additive zzso of zzso and zzso zzso and overcame the zzso zzso The enhanced efficacy of zzso was due to increased zzso cell death, rather than zzso These data strongly support that enhanced zzso zzso mediates zzso in zzso and identify a potential clinical niche for zzso zzso where zzso with zzso may be used in patients with zzso to overcome zzso 

